UK Government to launch first ever men’s health strategy
The strategy will consider how to prevent and tackle the biggest health problems affecting men of all ages. Credit: GoodStudio via Shutterstock.
As Men’s Health Awareness Month comes to an end, UK Health Secretary Wes Streeting has announced the development of a national strategy for men’s health.
The initiative aims to address key health challenges disproportionately affecting men, such as cardiovascular disease, prostate and testicular cancer, mental health issues, and suicide prevention.
The announcement was made at a Men’s Health Summit hosted by Arsenal Football Club in collaboration with men’s health awareness charity Movember, and the Premier League. The strategy – part of the Labour government’s proposed “ten-year plan” for the NHS – is expected to outline the government’s approach to addressing the growing challenges within the healthcare system.
According to the government, men in the UK die nearly four years earlier than women on average. They also face higher rates of preventable illnesses, such as heart disease and type 2 diabetes, and account for three out of four suicides. Despite these risks, men are less likely than women to seek medical help, particularly for mental health issues.
Streeting highlighted the urgency of the issue: “Preventable killers like heart disease and prostate cancer are being caught far too late. We’re seeing mental ill-health on the rise, and the shocking fact that suicide is the biggest killer for men under the age of 50.”
The strategy will include a public consultation to gather evidence on what is working and identify areas for improvement. Key topics include targeted prevention measures, closing the life expectancy gap between men and women, and exploring the viability of prostate cancer screening programmes.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
View profiles in store
Company Profile – free
sample
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
Country *
UK
USA
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint
Eustatius
and
Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean
Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Democratic Republic
of
the Congo
Cook Islands
Costa Rica
Côte d”Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern
Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and
McDonald
Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Lao
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia,
The
Former
Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint
Helena,
Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and
The
Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South
Georgia
and The South
Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
US Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
British Virgin Islands
US Virgin Islands
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Kosovo
Industry *
Academia & Education
Aerospace, Defense &
Security
Agriculture
Asset Management
Automotive
Banking & Payments
Chemicals
Construction
Consumer
Foodservice
Government, trade bodies
and NGOs
Health & Fitness
Hospitals & Healthcare
HR, Staffing &
Recruitment
Insurance
Investment Banking
Legal Services
Management Consulting
Marketing & Advertising
Media & Publishing
Medical Devices
Mining
Oil & Gas
Packaging
Pharmaceuticals
Power & Utilities
Private Equity
Real Estate
Retail
Sport
Technology
Telecom
Transportation &
Logistics
Travel, Tourism &
Hospitality
Venture Capital
Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.
Submit and
download
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
Currently, NHS guidelines for England say anyone can request a prostate-specific antigen (PSA) test if they are over the age of 50. However, there is currently no national screening programme for prostate cancer in the UK because there is no reliable test that can detect the illness requiring treatment at an early stage.
Recent attention on prostate cancer, sparked by Olympic cyclist Chris Hoy’s terminal diagnosis, has led to a surge in inquiries about the disease. In response, the NHS has committed to reviewing its advice on prostate cancer testing and examining potential screening options for high-risk groups.
Michelle Terry, CEO of men’s health charity Movember, welcomed the initiative: “Movember welcomes the government’s leadership on this and stands ready to work with the Secretary of State and his team to make the Men’s Health Strategy a reality that brings real change to lives up and down the country.”
This announcement follows the publication of a Women’s Health Strategy in 2022, where the Conservative government under Boris Johnson said that not enough focus is placed on women-specific issues such as miscarriage or menopause, and women are underrepresented when it comes to important clinical trials.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
No Byline Policy
Editorial Guidelines
Corrections Policy
Source